Suchergebnisse - "Arcaini, Luca"

PubPharm (373)

81

Perspectives and Emotional Experiences of Patients With Chronic Myeloid Leukemia During ENESTPath Clinical Trial and Treatment-Free Remission : Rationale and Protocol of the Italian Substudy

enthalten in: Frontiers in oncology | 2021

von Borghi, L. | Rosti, G. | Maggi, A. | +23

82

Enrichment of Double RUNX1 Mutations in Acute Leukemias of Ambiguous Lineage

enthalten in: Frontiers in oncology | 2021

von Merati, G. | Rossi, M. | Gallì, A. | +11

83

Prognostic impact of somatic mutations on time to first treatment : Results of targeted next‐generation sequencing in 211 patients with early stage chronic lymphocytic leukemia

enthalten in: American Journal of Hematology | 2021

von Varettoni, M. | Orlandi, E. | Zibellini, S. | +13

84

Mutational and immunogenetic landscape of HCV‐associated B‐cell lymphoproliferative disorders

enthalten in: American Journal of Hematology | 2021

von Defrancesco, I. | Visentini, M. | Zibellini, S. | +20

85

Antiviral prophylaxis for hepatitis B carriers affected by diffuse large B cell lymphoma : a matter of survival

enthalten in: British Journal of Haematology | 2021

von Zuccaro, V. | Bruno, R. | Arcaini, L.

86

COVID‐19 elicits an impaired antibody response against SARS‐CoV‐2 in patients with haematological malignancies

enthalten in: British Journal of Haematology | 2021

von Passamonti, F. | Romano, A. | Salvini, M. | +36

87

Direct‐acting antivirals in hepatitis C virus‐positive mantle cell lymphomas

enthalten in: Hematological Oncology | 2021

von Merli, M. | Marino, D. | Cencini, E. | +11

88

Acquired von Willebrand syndrome in myeloproliferative neoplasms with extreme thrombocytosis

enthalten in: Hematological Oncology | 2021

von Trotti, C. | Sant’Antonio, E. | Vanni, D. | +7

89

Direct-acting antiviral agents in lymphoproliferative disorders : more complex than expected

enthalten in: British journal of haematology | 2020

von Arcaini, L. | Bruno, R.

CommentOn: Br J Haematol. 2020 Dec;191(5):775-783. - PMID 32790920

90

Stem cell mobilization after bendamustine in indolent lymphomas : a multicenter study on behalf of the Fondazione Italiana Linfomi

enthalten in: Bone marrow transplantation | 2020

von Merli, M. | Luminari, S. | Farina, L. | +22